Do tradeoffs structure antibiotic inhibition, resistance, and resource use among soil-borne Streptomyces?

BMC Evolutionary Biology

Volumn 15, Issue 1, 2015, Pages

  Schlatter, Daniel C ^a   Kinkel, Linda L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIUM; FITNESS; GROWTH RATE; INHIBITION; LIFE HISTORY TRAIT; MICROBIAL COMMUNITY; NICHE BREADTH; PHENOTYPE; RESOURCE USE; SOIL MICROORGANISM; SPECIES DIVERSITY; TRADE-OFF;

STREPTOMYCES;

ANTIINFECTIVE AGENT; CARBON;

DRUG EFFECTS; ECOSYSTEM; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; STREPTOMYCES;

ANTI-BACTERIAL AGENTS; CARBON; ECOSYSTEM; SOIL MICROBIOLOGY; STREPTOMYCES;

EID: 84942198982     PISSN: None     EISSN: 14712148     Source Type: Journal    
DOI: 10.1186/s12862-015-0470-6     Document Type: Article

References (42)

1. Watve MG, Tickoo R, Jog MM, Bhole BD. How many antibiotics are produced by the genus Streptomyces? Arch Microbiol. 2001;176:386-90.
2. Williams S, Vickers J. The ecology of antibiotic production. Microb Ecol. 1986;12:43-52.
3. Firn RD, Jones CG. The evolution of secondary metabolism - a unifying model. Mol Microbiol. 2000;37:989-94.
4. Davelos AL, Kinkel LL, Samac DA. Spatial variation in frequency and intensity of antibiotic interactions among streptomycetes from prairie soil. Appl Environ Microbiol. 2004;70:1051-8.
5. Kinkel LL, Schlatter DC, Xiao K, Baines AD. Sympatric inhibition and niche differentiation suggest alternative coevolutionary trajectories among Streptomycetes. ISME J. 2014;8:249-56.
6. Weiner P, Egan S, Wellington EMH. Evidence for transfer of antibiotic resistance genes in soil populations of streptomycetes. Mol Ecol. 1998;7:1205-16.
7. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J. Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol. 2010;8:251-9.
8. Walsh F, Duffy B. The culturable soil antibiotic resistome: A community of multi-drug resistant bacteria. PLoS One. 2013;8:e65567.
9. Kneitel JM, Chase JM. Trade-offs in community ecology: linking spatial scales and species coexistence. Ecol Lett. 2004;7:69-80.
10. Tilman D. Diversification, biotic interchange, and the universal trade-off hypothesis. Am Nat. 2011;178:355-71.
11. Czárán TL. Chemical warfare between microbes promotes biodiversity. Proc Natl Acad Sci U S A. 2002;99:786-90.
12. Garbeva P, Tyc O, Remus-Emsermann MNP, van der Wal A, Vos M, Silby M, et al. No apparent costs for facultative antibiotic production by the soil bacterium Pseudomonas fluorescens pf0-1. PLoS ONE. 2011;6:e27266.
13. Kinkel LL, Bakker MG, Schlatter DC. A coevolutionary framework for managing disease-suppressive soils. Annu Rev Plant Physiol Plant Mol Biol. 2011;49:47-67.
14. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 2010;8:260-71.
15. Challis GL, Hopwood DA. Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Proc Natl Acad Sci U S A. 2003;100 Suppl 2:14555-61.
16. D'Costa VM, McGrann KM, Hughes DW, Wright GD. Sampling the antibiotic resistome. Science. 2006;311:374-7.
17. D'Costa VM, Griffiths E, Wright GD. Expanding the soil antibiotic resistome: exploring environmental diversity. Curr Opin Microbiol. 2007;10:481-9.
18. Thompson JN. The geographic mosaic of coevolution. Chicago: University of Chicago Press; 2005.
19. Bohannan BJM, Lenski RE. Linking genetic change to community evolution: insights from studies of bacteria and bacteriophage. Ecol Lett. 2000;3:362-77.
20. Thrall PH, Burdon JJ. Evolution of virulence in a plant host-pathogen metapopulation. Science. 2003;299:1735-7.
21. Hall AR, Scanlan PD, Buckling A. Bacteria-phage coevolution and the emergence of generalist pathogens. Am Nat. 2011;177:44-53.
22. Rigali S, Titgemeyer F, Barends S, Mulder S, Thomae AW, Hopwood DA, et al. Feast or famine: the global regulator DasR links nutrient stress to antibiotic production by Streptomyces. EMBO Rep. 2008;9:670-5.
23. Sánchez S, Chávez A, Forero A, García-Huante Y, Romero A, Sánchez M, et al. Carbon source regulation of antibiotic production. J Antibiot. 2010;63:442-59.
24. Van Wezel GP, McDowall KJ. The regulation of the secondary metabolism of Streptomyces: new links and experimental advances. Nat Prod Rep. 2011;28:1311.
25. Schlatter DC, DavelosBaines AL, Xiao K, Kinkel LL. Resource use of soilborne Streptomyces varies with location, phylogeny, and nitrogen amendment. Microb Ecol. 2013;99:961-71.
26. Davelos AL, Xiao K, Flor JM, Kinkel LL. Genetic and phenotypic traits of streptomycetes used to characterize antibiotic activities of field-collected microbes. Can J Microbiol. 2004;50:79-89.
27. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org/. 2013.
28. Hothorn T, Hornik K, van de Wiel MA, Zeilies A. Implementing a class of permutation tests; the coin package. J Stat Softw. 2008;28:1-23.
29. Vetsigian K, Jajoo R, Kishony R. Structure and evolution of Streptomyces interaction networks in soil and in silico. PLoS Biol. 2011;9:e1001184.
30. Bhullar K, Waglechner N, Pawlowski A, Koteva K, Banks ED, Johnston MD, et al. Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS ONE. 2012;7:e34953.
31. Yeh PJ, Hegreness MJ, Aiden AP, Kishony R. Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol. 2009;7:460-6.
32. Bibb MJ. Regulation of secondary metabolism in streptomycetes. Curr Opin Microbiol. 2005;8:208-15.
33. Takano E. Gamma-butyrolactones: Streptomyces signalling molecules regulating antibiotic production and differentiation. Curr Opin Microbiol. 2006;9:287-94.
34. Hsiao NH, Nakayama S, Merlo ME, de Vries M, Bunet R, Kitani S, et al. Analysis of two additional signaling molecules in Streptomyces coelicolor and the development of a butyrolactone-specific reporter system. Chem Biol. 2009;16:951-60.
35. Kitani S, Miyamoto KT, Takamatsu S, Herawati E, Iguchi H, Nishitomi K, et al. Avenolide, a Streptomyces hormone controlling antibiotic production in Streptomyces avermitilis. Proc Natl Acad Sci U S A. 2011;108:16410-5.
36. Levin BR, Perrot V, Walker N. Compensatory mutations, antibiotic resistance, and the population genetics of adaptive evolution in bacteria. Genetics. 2000;154:985-97.
37. Craig MacLean R, Hall AR, Perron GG, Buckling A. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat Rev Genet. 2010;11:405-14.
38. Vogwill T, Craig MacLean R. The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evol Appl. 2015;8:284-95.
39. Ward H, Perron GG, Maclean RC. The cost of multiple drug resistance in Pseudomonas aeruginosa. J Evol Biol. 2009;22:997-1003.
40. Angst DC, Hall AR. The cost of antibiotic resistance depends on evolutionary history in Escherichia coli. BMC Evol Biol. 2013;13:163.
41. Marshall GC, Broadhead G, Leskiw BK, Wright GD. D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc Natl Acad Sci U S A. 1997;94:6480-3.
42. Sander P, Springer B, Prammananan T, Sturmfels A, Kappler M, Pletschette M, et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob Agents Chemother. 2002;46:1204-11.